Higher AlphaB-Crystallin Levels Linked to Diabetic Retinopathy

Share this content:
Higher AlphaB-Crystallin Levels Linked to Diabetic Retinopathy
Higher AlphaB-Crystallin Levels Linked to Diabetic Retinopathy

WEDNESDAY, Dec. 21, 2016 (HealthDay News) -- Vitreous levels of alphaB-crystallin are significantly higher in eyes of patients with proliferative diabetic retinopathy (PDR) compared to the eyes of controls without diabetes, according to a study published online Dec. 7 in Clinical & Experimental Ophthalmology.

Wei Chen, Ph.D., from the Affiliated Hospital of Nantong University in China, and colleagues assessed vitreous samples collected before vitrectomy from 46 eyes of 46 consecutive patients with PDR and 19 patients without diabetes mellitus who had vitrectomy for idiopathic macular hole. Enzyme-linked immunosorbent assay was used to measure concentrations of alphaB-crystallin and vascular endothelial growth factor (VEGF).

The researchers found that the vitreous level of alphaB-crystallin was significantly higher in patients with PDR versus controls (P < 0.0001), as was the vitreous concentration of VEGF (P < 0.0001). Similarly, the expression levels of both alphaB-crystallin and VEGF were significantly higher in eyes with active PDR than in those with inactive PDR.

"These results suggest a significant increase of alphaB-crystallin in the vitreous fluid of patients with PDR and present a crucial association between alphaB-crystallin and VEGF with angiogenic activity in PDR," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »